Concepedia

Publication | Open Access

ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma

377

Citations

43

References

2015

Year

Abstract

Our data demonstrate the potential of ErbB2-specific NK-92/5.28.z cells for adoptive immunotherapy of glioblastoma, justifying evaluation of this approach for the treatment of ErbB2-positive GBM in clinical studies.

References

YearCitations

Page 1